Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing.
about
Genomics of adaptation during experimental evolution of the opportunistic pathogen Pseudomonas aeruginosaWhen the most potent combination of antibiotics selects for the greatest bacterial load: the smile-frown transitionFuture challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSAReduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsGenome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistanceMechanisms of drug resistance: daptomycin resistanceEndocarditis and molecular imagingMechanisms of vancomycin resistance in Staphylococcus aureusThe CEM-NET initiative: molecular biology and epidemiology in alliance--tracking antibiotic-resistant staphylococci and pneumococci in hospitals and in the communityInsights from genomic comparisons of genetically monomorphic bacterial pathogensStructural and functional characterization of Staphylococcus aureus dihydrodipicolinate synthaseMolecular Basis for the Role of Staphylococcus aureus Penicillin Binding Protein 4 in Antimicrobial ResistanceCrystal Structure of Staphylococcus aureus Metallopeptidase (Sapep) Reveals Large Domain Motions between the Manganese-bound and Apo-statesStructure and nucleotide specificity of Staphylococcus aureus dihydrodipicolinate reductase (DapB)Structure of an amidohydrolase, SACOL0085, from methicillin-resistantStaphylococcus aureusCOLMechanism of staphylococcal multiresistance plasmid replication origin assembly by the RepA proteinWithin-host evolution of bacterial pathogens.Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureusConsolidating and Exploring Antibiotic Resistance Gene Data ResourcesIdentification and characterization of sigma, a novel component of the Staphylococcus aureus stress and virulence responsesOptimal drug synergy in antimicrobial treatmentsGenetic architecture of intrinsic antibiotic susceptibilityEvolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKRWhole genome sequencing and complete genetic analysis reveals novel pathways to glycopeptide resistance in Staphylococcus aureusMultiple mutations in heterogeneous miltefosine-resistant Leishmania major population as determined by whole genome sequencingResponse of methicillin-resistant Staphylococcus aureus to amicoumacin AUsing a sequential regimen to eliminate bacteria at sublethal antibiotic dosagesWhole-Genome Sequencing for Routine Pathogen Surveillance in Public Health: a Population Snapshot of Invasive Staphylococcus aureus in EuropeMicroevolution of Helicobacter pylori during prolonged infection of single hosts and within familiesA timescale for evolution, population expansion, and spatial spread of an emerging clone of methicillin-resistant Staphylococcus aureusOrigins and evolution of antibiotic resistanceEpidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification.Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes.Beta-hemolysin promotes skin colonization by Staphylococcus aureusCeftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model.A mutation in the PP2C phosphatase gene in a Staphylococcus aureus USA300 clinical isolate with reduced susceptibility to vancomycin and daptomycin.Within-host bacterial diversity hinders accurate reconstruction of transmission networks from genomic distance data.The dominant Australian community-acquired methicillin-resistant Staphylococcus aureus clone ST93-IV [2B] is highly virulent and genetically distinctDifferent bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia.Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors
P2860
Q21144908-24AEB6AF-1802-40BD-B8F8-DFA6808E7CF0Q21145725-8B9EA788-B2F5-4B64-A5C8-50DAD7D37DEEQ22305769-B0465860-39EA-4C61-968C-4BAB2ACCFEF6Q24646677-28E36570-8E1E-4321-B23D-2316E8D65400Q24655140-35068F5F-5FC6-4DB6-90FC-8DE0BA8B478FQ26779944-B955C940-0C11-4FBF-A764-5870EEB142CEQ26823241-90AB3B96-7108-416E-9144-71CD2E1297EBQ26829312-B6E955A2-537C-4D33-B44E-E6C6BF2D8ED4Q26864354-80A75ACD-388C-4C6D-8061-D8325DE0EAA0Q27023806-F79D59B0-BAFB-416A-AB4C-DCB2E3788F76Q27651388-6B56157E-910E-4A8A-8BFA-D30A0F7AD605Q27657968-04222A59-B7B2-4BF1-A9D0-1E8E52965601Q27663269-97B9EDE6-B0FA-4D80-8C17-5B95878F50B8Q27671283-DB2C94FF-FE51-476F-88E2-3CDA9B16AF6BQ27676170-4A3AB1DB-9AAE-41CD-88B8-DBAA608EA654Q27684327-B050C5FD-6F9A-4864-85D8-F6E8878663CBQ28072013-7ED5B34A-AC58-47D6-9DEB-12CC288835F9Q28078930-A94E6932-A365-419D-80DA-9909E178B4D1Q28079668-EE0FEF79-FAE6-4690-89C5-C3293549AA71Q28474120-8F5BC6B4-8C33-4406-80F6-73EAD212FBEBQ28474170-6D9F9A6C-C439-492D-821D-AB66E37810DEQ28475506-EB1D7347-6E4E-4BE0-93F0-938D1709037EQ28477900-E6A9FD3A-B94E-47CB-8EC9-70E750C6D5AAQ28478770-9FF41B80-C557-4A05-AE99-46A3EA3960BAQ28480626-D884FCC4-1964-4B1A-9553-68946D4514FDQ28482069-246BC789-D711-48E2-B8CC-F8F16EE8A922Q28545933-15D5C943-73FE-44C4-BE0B-C4EF37082665Q28595903-0BE989DB-3EA4-4FF2-8593-E36F7C8533C2Q28750235-4AAE7C21-103A-480D-906F-005FD846A9B5Q28752649-8814814C-270F-4642-A4A8-77CBE713906FQ29617791-E23D67FD-E987-4744-9B2E-D46A63D6BDBEQ30367325-091C04A4-1F77-4072-B6E5-05AFA155ADFEQ30426714-343BB5E1-244A-4DB5-BF52-09A1E4EE672EQ30449958-BDD17143-178F-4D22-A2A1-3B4EF330355AQ30452801-94BB7D58-FE9E-432F-BE61-2053D88F889BQ30455758-AE79BE67-5D91-4C31-89E8-B470D62830EAQ30787069-45637271-7BB7-4FDF-A7BB-EE802416D389Q31032795-98FAF4DA-3955-4500-A359-4BB67132490BQ33321447-305F255D-63E1-4B2C-BBB9-537DBAF679F2Q33339829-7DB24DA7-487A-499F-AB6B-B45883E83C26
P2860
Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Tracking the in vivo evolution ...... us by whole-genome sequencing.
@ast
Tracking the in vivo evolution ...... us by whole-genome sequencing.
@en
Tracking the in vivo evolution ...... us by whole-genome sequencing.
@nl
type
label
Tracking the in vivo evolution ...... us by whole-genome sequencing.
@ast
Tracking the in vivo evolution ...... us by whole-genome sequencing.
@en
Tracking the in vivo evolution ...... us by whole-genome sequencing.
@nl
prefLabel
Tracking the in vivo evolution ...... us by whole-genome sequencing.
@ast
Tracking the in vivo evolution ...... us by whole-genome sequencing.
@en
Tracking the in vivo evolution ...... us by whole-genome sequencing.
@nl
P2093
P2860
P50
P356
P1476
Tracking the in vivo evolution ...... us by whole-genome sequencing.
@en
P2093
David Bruce
Eric D Siggia
Herminia de Lencastre
Krzysztof Sieradzki
Michael M Mwangi
Paul Richardson
Shang Wei Wu
Yanjiao Zhou
P2860
P304
P356
10.1073/PNAS.0609839104
P407
P577
2007-05-21T00:00:00Z